Has Michael Mirzabeigi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $71,167 in general payments to Michael Mirzabeigi, MD across 106 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Mirzabeigi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Mirzabeigi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Mirzabeigi, MD

Plastic and Reconstructive Surgery · Atlanta, GANPI 1366703258

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $50,232 of the $71,167 with a category attached, or 70.6%. 13 manufacturers reported payments, led by Bimini Technologies LLC at 54.1% of the total. 2025 is the largest year on record at $42,455, more than ten times the $951 reported in 2019. Among plastic and reconstructive surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,167in general payments, 2019–2025

Across 106 payments — averaging $671.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bimini Technologies LLC$39K
RTI Surgical, Inc$16K
Axogen$9K
Sientra, Inc.$3K
AbbVie$2K
Kerecis Limited$314
plus $1K from 7 others

What the payments were for

Consulting fees$50,23271%
Speaking & faculty fees$13,90020%
Travel & lodging$450%
Food & beverage$6,99010%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bimini Technologies LLC	1	$38,500
RTI Surgical, Inc	14	$16,421
Axogen	41	$8,963
Sientra, Inc.	10	$3,424
AbbVie(2 entities)	24	$2,457
Kerecis Limited	3	$314
Mentor Worldwide LLC	4	$291
Integra Lifesciences Corporation	4	$245
Tepha Inc	1	$166
Baxter Healthcare	1	$149
TELA Bio, Inc.	1	$137
Musculoskeletal Transplant Foundation Inc.	1	$57
BD	1	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CORTIVA ALLOGRAFT DERMIS$16,400
AVANCE NERVE GRAFT$7,975
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$3,285
AxoGuard Nerve Connector$1,540
AxoGuard Nerve Protector$1,540
NATRELLE SALINE-FILLED BREAST IMPLANTS$1,146
ALLODERM$761
INTEGRA$503
Kerecis Omega3 SurgiClose$432
INTEGRA DERMAL REGENERATION TEMPLATE$168
PRIMATRIX$168
GalaFLEX$166
PerClot$149
Kerecis Omega3 GraftGuide$144
Kerecis Omega3 Marigen$144
MENTOR MemoryGel Resterilizable Gel Sizer$142
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$137
NATRELLE$109

How this compares

$71,167 in reported general payments places this provider in the 95th percentile of 83 plastic and reconstructive surgery providers in Georgia.

See all plastic and reconstructive surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$57,354

Medicare patients

Services billed

153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	35	$104
Ondansetron OdtOndansetron	13	$72
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	16	$70
Cephalexin	11	$39
Methocarbamol	16	$32
Promethazine Hcl	16	$27

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Atlanta

Carmen KavaliAtlanta$233K
James NamnoumAtlanta$97K
Katherine SantosaAtlanta$65K
Alexis TashimaAtlanta$22K
Kristin BoehmAtlanta$18K
Grace MaAtlanta$17K
Lindsey WebbAtlanta$10K
Mark CrispinAtlanta$6K
Joseph WilliamsAtlanta$5K
Paul GhareebAtlanta$4K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →